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Experimental Studies in Whole Animal
Bioassay*
Animal models have been used for a number of
purposes in metal carcinogenesis studies: (a) to
detect carcinogenic activity; (b) to estimate
carcinogenic risk; and (c) toinvestigate mechanisms
of metal carcinogenesis.
The design ofanimal tests will be determined by
the purpose of the study. In this section we shall
distinguish between tests in animals designed to
identify carcinogenic activity versus tests intended
tohave specialrelevance tothe evaluation ofeffects
in man.
Tests of Carcinogenic Activity
General Principles
Guidelines for decisions relative to the carcino-
genicity of a metal in experimental animals will
includethedetermninationofthepurity, thespeciation,
and the physical state ofthe metal compound being
evaluated in the experimental animals (1).
At the present state ofknowledge, short-term or
in vitro tests are valuable research tools for metal
carcinogenesis studies, e.g., molecular mechanisms,
but no test or battery oftests has been sufficiently
validated to be used reliably in predicting the
carcinogenic activity of metal compounds in ani-
mals. Tests in whole animals are necessary for the
experimental identification ofcarcinogenic activity.
The intramuscular route of administration has
been used to study the carcinogenic potential of
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numerous metal compounds. Tumors appear at the
site between4 to 11 months (afewfirst appearafter
12 months). The subcutaneous route is the second
most frequent one by which positive results were
obtained with metals. Solid-state carcinogenesis
may complicate the interpretation oftumors which
appear at the site of implantation by this route.
Occurrence of tumors only at the site of injection
should be followed by studies employing other
routes of administration.
Intratracheal instillation has been employed to
study the carcinogenic or enhancing effects of
several metal compounds. Larger doses can be
administered, and maximum tolerated dose can be
approximated by this route of administration.
The oral route has been traditionally used for
carcinogenic studies of nonmetals. This route has
limitations for metal studies since some metals are
poorly absorbed from the gastrointestinal tract.
Diet and watermust be analyzed formetal content.
Most commercial rodent diets are high in calcium,
zinc phosphates, andphytates, which interfere with
metal absorption. The metal being studied must
alsobe analyzed in the control diet. Blood and urine
levels ofthe agent under test must be measured to
obtain some indication of the amount of the metal
absorbed.
Special routes of administration may be used to
answer specific questions, such as the intrathoracic
route to induce mesotheliomas.
Itmust be recognized that, although a metalmay
be carcinogenic in one or more species or strains,
e.g., in rats, mice, hamsters, no generalization can
be made about interspecies comparison. Species
differences in relation to metal metabolism can
have profound effects on the outcome of experi-
ments. From a practical viewpoint, rodents are the
animals of choice, but more research is needed to
determine the carcinogenic response of other or-
ders. Bioassays on more than one species are
21necessary to reduce the possibility of missing the
carcinogenic action of a metal.
Amajorareaofresearchwhichhasbeenneglected
is transplacental and perinatal carcinogenesis by
metals. Here the experiments must be so designed
as to differentiate intrauterine exposure, neonatal
exposure, and exposure through the maternal milk.
Relation to in Vitro Studies
Presently, short-term in vitro bioassays are
under development for detection of metals as
carcinogenic agents viabothgenetic andnongenetic
pathways. Current research efforts directed to-
ward improvement of in vitro techniques for the
detection of metal carcinogens continue to rely
heavily on information obtained from in vivo bioas-
say. It is expected that, with further development
of in vitro bioassays, complex mixtures and key
elemental interactions may be screened in vitro
prior to in vivo testing. Furthermore, because of
the flexibility of in vitro bioassays, such systems
mayprovide clues onhowto conductinvivotests in
the most efficient manner. A major difference,
however, between in vitro systems and the in vivo
assays relates to chemical speciation. In vivo re-
sponse is markedly dependent on chemical form,
i.e., Ni3S2 vs. NiS vs. NiSO4, and low and high
temperature forms of BeO. Understanding of the
effects of different chemical species of metals,
however, will provide insight intothemechanism of
metal carcinogenesis.
Estimation of Carcinogenic Risk
Comparisons of Carcinogenic Activity
Carcinogenic activity in animal experimentation
relates to the dose that causes a given frequency
and incidence of cancer under controlled experi-
mental circumstances, species, strain, age, and sex
of the experimental animals. The ability to detect
carcinogenic activity is also determined by number
ofanimals, positive and negative controls, period of
observation, and so forth. Carcinogenic activity is a
relative term and implies a comparison with other
chemicals such as weak versus strong carcinogens
(2).
Measurements of carcinogenic activity are used
for experimental purposes, for example, in studies
of structure-activity relationships, identifying the
"proximate" carcinogen, or assessing the effects of
modifying factors on the carcinogenic response.
Measurement of weak versus strong carcinogenic
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substances in experimental animals have been ex-
trapolated as estimated of relative risks in the
human populations for exposures to one substance
versus another.
Relevance of Animal Tests to Man
In order to predict hazard to man from animal
studies, there must be judicious selection of test
species, routes ofexposure, and dose. Tests such as
in vitro tests and/or in vivo tests such as intramus-
cular or subcutaneous injection may or may not
precede the use of more relevant exposure tech-
niques.
Selection ofTestAnimals. Because of ease of
handling, accumulated long-term experience, and
the capability of the investigator to manipulate
fairly large groups of animals, it is likely that the
animals chosen for whole animal tests will, in most
instances, be standard laboratory rodents, that is,
mice, rats, and hamsters. It is essential, however,
to recognize the possible shortcomings of this
approach. Absorption, transport, storage, excre-
tion, and qualitative and quantitative aspects of
biotransformation of metal compounds may vary
considerably among rodents and between rodents
and humans. Similarly, differences in interaction
with target macromolecules and differences in re-
paircapability may be significant determinations of
variations in response.
The use of two or more test species will reduce
the likelihood ofconfusing species-specific responses
from those applicable to man. Certainly, differ-
ences in response among rodent species should be
exploited to illuminate the mechanisms of carcino-
genesis.
Routes of Administration. An experimental
protocol designed to assist in the estimation of
human risk should preferentially employ routes of
administration identical to or as similar as possible
to those involved in human exposure. The route
chosen will determine the effect ofthe test material
on tissues immediately contacted as well as on
tissues ultimately reached by absorbed and
metabolically altered products. Thus, feeding ex-
periments alone are not sufficient to examine sys-
temic carcinogenicity ofa material poorly absorbed
through the intestine as is the case with many
metal compounds. Some metals, although poorly
absorbed, may nevertheless accumulate over a
lifetime.
Dose. It has become customary to utilize the
estimated "maximum tolerated dose" in the design
of initial bioassays in animals. The justification for
this choice has beenthenecessitytoexplore the full
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limitation ofdetectable effects imposed by use of a
relatively small group of animals. These should be
considered preliminary studies to demonstrate the
carcinogenic potential of the substance. However,
extrapolation of findings to long-term, lower level
exposure in larger groups of humans may require
studies at different dose levels. For example, high
dose metabolism may differ significantly from me-
tabolism of lesser quantities of metal compounds.
High doses, not inconsistent with those occasionally
encountered by humans, may produce severe inter-
fering toxic effects. Accordingly, the experimental
design should include lower doses that do not
produce such toxicity. Patterns of dosage may
include such things as intermittent exposure, short-
term high level exposure followed by prolonged
observation, or even single dose exposure, particu-
larly to refractory materials with long biological
half lives.
Careful attention must be given to those deter-
minants of dose other than total quantity. These
include such factors as particle size, solubility,
stability, and the metabolic pathways which deter-
mine ultimate dose to the target tissue and cell.
Comparison ofAnimal Studies with Epidemi-
ological Findings in Man. Bioassay of metal
compounds in experimental animals may be predic-
tive ofeffects in man. Although there are anumber
ofquantitative differences between various species
of laboratory animals and man, there is a basic
universality of biological systems that permits
extrapolation of effects in animals to man (3-5).
Idealiy, animal studies should provide sufficient
information regarding the carcinogenic potential of
metal compounds to support regulatory measures
that are protective to human health. In those
instances where human effects have already oc-
curred or are suspected, animal studies may confirm
the activity of a specific substance and route of
exposure and may also elucidate mechanisms and
factors that influence effects in man.
To date, exposures to arsenic, beryllium, cadmi-
um, chromium, and nickel (or their compounds)
have been identified as contributing to the devel-
opment ofhuman cancer (6). Certain compounds of
beryllium, nickel, and chromium, which are ac-
cepted as contributingto pulmonary cancer in man,
also produce tumors in animals exposed via the
respiratory tract. Animal models treated by similar
routes ofexposure produce tumors with compounds
of these metals.
Arsenic has been linked through epidemiologic
studies to skin cancers following ingestion ofAs in
drinldng water and Fowler's solution and to carci-
noma ofthe lung in workers exposed by inhalation
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(7). In spite of extensive investigation in diverse
animal species, there is no definite evidence that
arsenic is carcinogenic for experimental animals.
Recent studies, however, involving intratracheal
administration of a mixture containing arsenic,
copper sulfate, and calcium oxide resulted in pul-
monary tumors (8). These findings point to differ-
ences of susceptibility to arsenic compounds be-
tween man and certain experimental animals. Also,
the epidemiologic studies may reflect other mixed
exposures ofwhich arsenic is only one component of
exposure to specific forms of inorganic arsenic.
Prostatic cancer has not been found following
administration of cadmium by gastric gavage or
injection, but these studies resulted in low tissue
content of metal (9). There have been no reported
long-term studies of inhalation of cadmium com-
pounds in animal models for carcinogenesis. Intra-
muscular and subcutaneous injection resulted in
sarcomas at the site ofinjection. Testicular tumors
were found after systemic intratesticular injection
in fowl.
Anumberofmetalcompoundshavebeenreported
to cause tumors in experimental animals, but
corresponding carcinogenicity has not been estab-
lished by studies in man. Cobalt, manganese,
titanium, zinc, and carbohydrate-iron compounds
each produce tumors by parenteral routes at the
site of injection, a route of exposure not likely to
occur in man (10). Such studies by injection routes
may, however, provide incentive for further stud-
ies employingotherroutes ofexposures. Also, such
studies may be predictive of implant effects, per-
haps relative to usage of materials for prosthesis,
although the role of physical factors as well as the
chemical nature of the metal compound must be
considered in such evaluations.
Lead is the only metal to date that produced
tumors in rats following oral administration (11).
There are some epidemiological data regarding the
carcinogenicity of lead in man (see Epidemiology
Report). These data, however, do not provide
sufficient evidence to support definite conclusions
as to whether lead causes human cancer (12).
Differences in susceptibility to toxicity between
man and experimental animals may permit levels of
exposure to the metal in experimental animals that
cannot be tolerated in man, thus leading to discrep-
ancies between epidemiological observations and
animal studies.
It is concluded that the relevance of animal
studies to man is closer when the same metal
compound produces tumors by similar routes of
exposure in man and animal models, produces
tumors in common target organs, and produces
tumors in different animal orders.
23Mechanisms of Metal
Carcinogenesis
Route of exposure appears to be an important
factorinmetalcarcinogenesis. Itisgenerallydifficult
to produce tumors by adding metals to food or
water, since absorption from the gastrointestinal
tract is often poor.
Metabolism is an important aspect in considering
mechanisms ofmetal carcinogenesis. Quantification
of initial deposition of the metal in target tissues
(lung, skin), eventual translocation to susceptible
tissues (bone, kidney), and persistence of metals
within their target are important elements in
understanding and possibly predicting mechanisms.
A substantial amount of data indicates that
solubility, valence state, oxidation-reduction reac-
tions, and formation of complexes are important
determinants in metal carcinogenesis (13). It will
not be adequate to obtain in vivo data on the
behavior of metallic cations only. Experimental
approaches need to be developed which allow the
study ofpossible biotransformation and behavior of
metals in complex biological surroundings.
It is the prevailing hypothesis that some metals
cause cancer by inducing damage directly to the
genome (14-18). The evidence has been summarized
in recent reviews (1, 19). Less data from whole
animal studies are available to support the hypoth-
esis. Such information should become available.
However, it would appear important that the
experimental model be carefully selected. Unless a
given experimental approach will produce a high
tumor response in vivo, it will not be possible to
link, with confidence, molecular or cellular changes
directly to the eventual development of cancer.
Metalcompounds mayalsoproduce tumorsthrough
nongenetic mechanisms. One notion is that metals
are promoters. Furthermore, their effects on intra-
cellular metabolism make cells more susceptible to
initiation. Certain platinum compounds have been
shown to be carcinogenic in animals and to act as
initiators for the mouse skin (20). There is a large
amount of information available on how metals
inhibit enzymes, bind to cellular macromolecules
other than DNA (nuclear proteins, RNA), bind to
receptors or interfere with membrane functions.
Some ofthese adverse effects are quite specific for
either aparticular enzyme orfor aparticular metal.
They often occur at metal concentrations which are
orders of magnitudes below those found to induce
genetic damage. In at least some circumstances,
metal carcinogenesis may be mediated by trophic
hormone effects. A possible example is induction of
Leydig cell tumors in rats following testicular
necrosis after subcutaneous injection of CdCl2 (21).
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The relation of immune response to metal
carcinogenesis has received too little attention thus
far. Certain metals (e.g., Pb) appear to suppress
the general immunocompetence of the host, but
other metals (e.g., Be) were shown to have aller-
genic properties. With beryllium, inhalation expo-
sure has suppressed a previously induced cutane-
ous hypersensitivity to the same ionic species ofthe
metal (22).
Metalinteractions incarcinogenesis have recently
been reviewed (23-25). Interactions may be divided
into the following areas: (a) metal antagonism or
synergism with metal carcinogens; (b) metal antag-
onism or synergism with organic chemical carcino-
gens; and (c) biological factors affecting the expres-
sion ofchemical carcinogenesis. A major limitation
ininterpretingthe health significance ofco-exposure
from complex mistures is the lack of specific infor-
mation on the chemical form of the biologically
active element.
Clearly, fromatoxicologicalandnutritionalstand-
point, metal-metalinteractionsarewelldocumented,
i.e., Zn-Cd, Ca-Zn, Cu-Zn, Se-Hg, Se-Cd, etc. Few
carcinogenesis studies, however, have examined
such interactions. Co-exposure of zinc acetate and
cadmium chloride (21) or manganese metal and
nickel subsulfide (26) have resulted in substantial
reductions in tumor incidence. Metabolic studies of
the Mn-Ni system have not elucidated the mecha-
nism ofantagonism. Thus, furtherwork is required
to evaluate the carcinogenicity of co-exposures.
Furthermore, in light ofthe increasing evidence of
varied essential and nonessential elemental expo-
sure in human populations, nutritional status must
be considered in the evaluation of the totality of
human exposures to trace elements.
Trace element exposure often occurs in combina-
tion with organic chemical carcinogens. Inhibition
of carcinogenesis has been described with copper
and selenium compounds. Azo-dye hepatocarcino-
genesis may be entirely suppressed by dietary
coppersupplementation probably duetomore rapid
catabolism via azo reduction (27). On the other
hand, copper protection against ethionine induced
hepatomas is thought to be due to decreased
catabolism and increased hepatotoxicity (28). Such
studies demonstrates the potential complexity of
metal interactions.
The best evidence of synergism results from
studies of respiratory tract co-exposure to inor-
ganic particles and organic carcinogens (29). Al-
though the mechanism is not completely under-
stood, rate ofrelease ofcarcinogen and particle size
appear to be important factors in the incidence of
respiratory tract tumors. Arsenic activity might be
related to exposures of mixtures. However, the
Environmental Health Perspectivesrole ofarsenic as a cocarcinogen is unclear. Recent
studies indicate an important role for trace ele-
ments as regulators of the immune system as well
as activators of viral expression. For example,
dietary zinc status may alter the growth rate and
incidence of metastases of transplanted tumors
(30).
Recommendations
1. The investigation of metabolic conversions
involving oxidation states in vivo and in vitro
and the relationship to biological effects should
be studied.
2. The development and improvement ofanalyti-
cal methods should be undertaken to identify
biologically active chemical species.
3. The investigation of the role of immune re-
sponse to metal compounds and metal hyper-
sensitivity for metal carcinogenesis should be
examined.
4. Investigation of the role of metals as
cocarcinogens and promoters need to be
investigated. Animal as well as in vitro
models are required for examination of
possible promoting activity for metal
compounds.
5. Analytical techniques for speciation of metal
compounds in complex mixtures (e.g., coal fly
ash) and in body tissues should be developed.
6. There should be consideration of more re-
search onthe carcinogenic response ofanimals
other than rodents, such as avian and aquatic
types (10, 11).
7. Further studies of carcinogenesis resulting
from perinatal and transplacental exposure
are required.
8. The synergism and antagonism between metal
compounds, particles and organic chemical
carcinogens, and the underlying mechanisms,
should be investigated.
9. Methods relevant to the carcinogenesis
testing of alloys and metallic substances
that are being used for prostheses for
dentistry, orthopedics and for artificial
internal organs should be developed.
10. The role of chemical and physical forms in
their carcinogenicity should be investigated
for selected metals.
11. The assessment of carcinogenic activity in an
animal model which suggests the possibility
that a metal compound may have a cancer
inhibitive or an anticarcinogenic effect should
be carefully defined and given emphasis in the
planning of further investigations. The possi-
bility that selenium and zinc in certain
circumstances mayhaveanticarcinogenic effects
requires further investigation.
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